Reverse Logistics in Pharmaceutical Industry
Reverse Logistics in Pharmaceutical Industry of Pakistan using the Multiple
Integer Linear Programming
Asif Rafique Bhatti
1200405-1003
PhD Scholar
School of Business and Economics
University of Management and Technology, Lahore
February 26, 2013
1
Reverse Logistics in Pharmaceutical Industry
Abstract
In this paper Reverse logistics in Pharmaceutical industry of Pakistan has been
modeled using the mixed integer linear programming. Considering the time horizon,
multiple products, multiple distribution returns and multiple collection centers. The
idea is to come up with solution to minimize the cost of overall returns in the domain
of what if organization open collection center or not considering the need
periodically. However scope is limited only for the returns which are shipped due to
breakage / Expire. We have not taken returns which are due to wrong dispatch /
excess or shortages returns due to wrong packages etc.
Keywords: Reverse logistics (RL), Reverse supply chain (RSC), Product
Distributors (PD), Forward Logistics (FW)
Introduction
Pakistan is one of those regions where the Pharma industry is now become a
major contributor in national growth. Earlier Pakistan has very few Pharma
manufacturing industries, at the time of establishment 1947. Now it is worth
mentioning that currently around 400 national and Multinational market players are
working in Pharma sector of Pakistan. The value of product sold in year 2007 was
US$1.4bn and value of product sold in year 2012 was recorded up to US$2.3 bn.
Now Pakistan is developing Pharmaceutical market in Asia with large population and
economic progress. Pakistan Pharma sector is relatively young in international drug
market with exports over US$100 million in year 2007 and the industry export vision
is US$500 million by 2013 (PPMA 2012). Current growth rate 19-20% and market
2
Reverse Logistics in Pharmaceutical Industry
Size around 2 billion US Dollar. Pakistani Pharma Industry in the frame of global
rank in term of Volume wise ranked at 10th and in term of value wise industry marked
at 50th number. Pakistani Pharma industry employed approx ½ million people directly
or indirectly.
In current scenario where the regulatory concern and economical factors
making the competition more stiff, the drug manufacturers are focusing on the
excellence in operations to excel in quality and efficiency.
Supply Chain Management
Supply Chain Management offers supports and integration in multiple
domains of business. In supply chain management the return part appears in customer
services. For example SCM defined supply chain as, it consists of all parties involve,
directly or indirectly, in fulfilling the customer request. The supply chain includes not
only the manufacturer and suppliers but also transporters, warehouse, retailers and
even customer themselves (Chopra, 2009). On the other hand council of supply chain
Management defines the supply chain as “Supply chain management encompasses the
planning and management of all activities involved in sourcing and procurement,
conversion, and all logistics management activities. Importantly, it also includes
coordination and collaboration with channel partners, which can be suppliers,
intermediaries, third party service providers, and customers. In essence, supply chain
management integrates supply and demand management within and across
companies” (CSCMP, 2013).
It can be infrared that the reverse logistics part is not mentioned in these
definitions but it is implied that the focal firm has to answer all the request of the
3
Reverse Logistics in Pharmaceutical Industry
customers using any of the tool available under the umbrella of supply chain
Management.
As logistics in supply chain Management as CSCMP’s Definition of Logistics
Management
“Logistics management is that part of supply chain management that plans,
implements, and controls the efficient, effective forward and reverses flow and
storage of goods, services and related information between the point of origin and the
point of consumption in order to meet customers' requirements.”(CSCMP, 2013).
In the context of Pakistani Pharmaceutical industry the forward logistics is
truly the value added service from the manufacturer to support the customer by
optimization of the customer services and cost associated with this operation.
Reverse Logistics
Reverse logistic is the backward flow of product from customer to the point of
origin, in reverse logistic the flow is from “Many to One”. On the other hand forward
flow of logistics the product is distributed to different channels from one source “One
to many.”
According to the American Reverse Logistics Executive Council, Reverse
Logistics is defined as, “The process of planning, implementing, and controlling the
efficient, cost effective flow of raw materials, in-process inventory, finished goods
and related information from the point of consumption to the point of origin for the
purpose of recapturing value or proper disposal.”
4
Reverse Logistics in Pharmaceutical Industry
Reverse Logistics in Supply Chain Management Figure 01
Source: Samir and Rajiv 2006: 36.
Reverse Supply chain Management defines as “the Managing the series of the
activities which require to retrieve the product from the customer to dispose the
product or recover value.”
In nutshell RSCM is emerging concept in context of the Pakistan as there are
no specialized services available in this domain. Legalization and environmental
concerns are now forcing the manufacturers to manage this reverse flow. Reverse
logistics in corporate world is objective by the collection of end of life product,
damage product or wastage by meeting the business social responsibility with
5
Reverse Logistics in Pharmaceutical Industry
minimum input of the cost. The importance of studying the RSCN has increased for
several reasons for instance
The amount of sold unit return is high and that can hit hard to future sales
To maintain the social image of the corporate sector in the eye of the
customers
To stream line the Product Distributors (PD) concerns on revenue loss in case
of end of Life (EOL) / Damage / defected products
To meet the standers of the Legalization
To generate the value if possible
Reverse Logistics and Pharmaceutical industry of Pakistan
RL in the Pharmaceutical industry is as important as the forward logistics. Its
importance is not only for the sake of economical factors but also from the point of
view of the regularity and environmental concerns. In one of the leading economies
like in America the total Pharmaceutical return is 2.5 billion dollars and an estimated
reverse flow of goods worth about 5 million dollars. Some of the common reasons
which cause to return of Pharmaceutical products are:
Near expiry or expired
Damage / Breakage ( Glass Bottles of Syrups )
Wrong Batch dispatch
Product Recalls
Regulatory concerns if any
6
Reverse Logistics in Pharmaceutical Industry
In Pakistani Domain it takes important considerations for the industry when it
comes to reverse logistics are the security of the returned goods and cost parameters
of the RSCM, It become important to answer the questions that :
What they should consider in RSCM Product wise?
Why it is important to go far RSCM?
Who will responsible for it?
What should be the rout (Location) for collection?
How much cost would incur on it?
The nature of return in Pharmaceutical industry is bit different to the return of
the other industry. For instant in plastic or soft drink manufacturing industry when the
product is return it will move towards the remanufacturing / refilling or disposal.
While on other hand in Pharmaceutical industry when product is return from the
Product Distributors (PD) these products need to be destroyed and disposed properly.
7
Reverse Logistics in Pharmaceutical Industry
Fig 02 Reverse logistics Pharmaceutical Industry
Current position of RSCM in Pakistan:
Currently in Pakistan there are few names who are taken reverse logistics as
business , and earning a handsome profit by using the waste or other industrial
returns of different kind by adding the value .but overall the situation not satisfactory
regarding the industries intention and focus on reverse logistics. In Frame work of
Reverse logistics (Ijaz Yousuf, 2012) has mention the road blocks of RL specifically
in Pakistani Industry
Lack of awareness about reverse logistics
Lack of technical expertise to manage the Returns
Management Intentions ( strategic focus )
8
Reverse Logistics in Pharmaceutical Industry
Financial constrains
Information sharing issues
Lack of Infrastructure
Environmental and Legal Issues
However with situation like this in case of Pakistani Industrial frame, there is
still a room to establish a sense for taking the RL at strategic level by figuring out its
importance.
Objective of the paper
This paper is an effort to investigate the Reverse supply chain for a
Pharmaceutical organization using the mixed integer linear programming where the
organization is planning to incubate the Reverse logistics network by opening
collection centers, processing center, deploy human resource and other parameters to
manage the returns either to dispose it or distraction and relevant with the objective is
to minimize cost of overall Return supply chain.
Previous Work in RSCM using the MI Linear Programming
In different research paper the researcher has highlighted the complex and
uncertain nature of the RL. According to literature the one of the important
characteristics of RL is the uncertainty that ultimately oscillate the RL systems in
different parameters of RSCM. (Roghanian & Mostafa, 2012) Hosseinzadeh presented
work on reverse logistics using the mixed integer linear programming with the addition
of the genetic Algorithm with the system base assumption for the multiple products,
9
Reverse Logistics in Pharmaceutical Industry
multiple collection points, multiple processing centers and transportation strategy that will
satisfies demand imposed by manufacturing centers and recycling centers with minimum
fixed opening cost and total shipping cost. Then, they propose priority based genetic
algorithm to find reverse logistics network to satisfy the demand imposed by manufacturing
centers and recycling centers with minimum total cost under uncertainty condition. Finally,
authors have applied the proposed model to a numerical example. This was intentioned to
facilitate which processing, collection, manufacturing center has to open or not. Ko and
Evans presented a mixed integer nonlinear programming model for the design of a dynamic
integrated distribution network to account for the integrated aspect of optimizing the forward
and return network simultaneously.
In same domain Jayaraman (1999) has presented a closed loop logistics model
using the Mixed Integer Programming in which the decision regarding the shipment,
remanufacturing. Location of stores or establishing the facilities are taken in to
account. The model that was presented by the Jayaraman was in the form of 0 or 1
integer programming. The objective was to minimize overall cost of close loop
supply chain which includes the product returns, transportation cost, and facility
opening cost. Other modeling techniques have been incorporated in reverse logistic
for instance; Fleischmann (2001) has modeled the reverse logistics Network design
by considering the impact of Product returns on logistics networks.
Min (2006) has contributed in the reverse logistics by introducing mixed-
integer, nonlinear programming model and a genetic algorithm for its solution.
Numerous studies have been found which shows the research on the reverse logistic
network design and route problems, researchers has used the transportation model to
describe the possible results in the frame of MI programming.
10
Reverse Logistics in Pharmaceutical Industry
Hypothetical Case Study
To develop a model we have assumed a Pharmaceutical organization who is
interested to introduce a reverse supply chain Management (RSCM). The company has over
an X billion US Dollar Business in Pakistan and has wide range of Product distributor all
over the Pakistan. Currently organization has full developed forward supply chain (Forward
Logistics) but facing problem in the domain of RSCM. In past years the return rate was X
(Average) of total sale, which include both the disposal and destruction. Company is
expecting X% increase in year 2014. Company is currently operating from it National
warehouse Lahore by feeding the demand of the entire X Product distributor (PD) in
Pakistan. Management is in process to open the facilities / facility in one of the key location
considers the cost factor in mind to entertain the Return Processing center. Nature of return
includes two kind of products syrups (destructions) and disposal (Bluster Packs). Any facility
open in any point should not cost more than X Pak Rupee. In addition the management has
option to hire a third party (outsource) the RSCM process either from warehouse or from
each collection centers. Considering all the requirements we have used MI linear
programming to formulate a model.
11
Reverse Logistics in Pharmaceutical Industry
Overview of Operational Frame work of RSCM
PD1
S1
PD2
S2
PD3
FOCAL FIRM
WAREHOUSE
Manufacture
S3
RL PD4
S4 FL
PD5
Dispose Destructio
n
12
Reverse Logistics in Pharmaceutical Industry
Assumption
Transportation rates are already known
Return only include Damage / Expire
Warehouse in centrally located
Damage / Return Rate is know
Disposal and Destruction charges are known
Land cleaning rates are known
Cost of subcontracting is known
Model
Indices:
D= Set of the all the distributors (d= 1, 2, ---, 24)
J= Set of the all the products (j= 1, - - - , n)
M= number of the collection center (m = 1, - - -, n)
P= number of Periods (P = 1, - - - - , n)
X1 = amount of the product which is destructed in collection center
X2= amount of the product which is disposed in collection center
Q = warehouse Facility for return products
13
Reverse Logistics in Pharmaceutical Industry
Variables:
Qjdp = amount of return products (j) which is shipped from Distributor (d) at
warehouse point in Period (P)
Wjmdp = amount of return products ( j ) which are shipped form Distributor ( d ) at
collection center in period (p)
Rx1jpm = amount of the returns products (j) mover from Collection center (m) to
destruction center (x1) in period (p)
Rx2jpm = amount of the returns products (j) mover from Collection center (m) to
disposal center (x2) in period (p)
Mx1jpq = amount of the returns products (j) mover from warehouse (Q) to
destruction center (x1) in period (p)
Mx2jpq = amount of the returns products (j) mover from warehouse (Q) to disposal
center (x2) in Period (P)
Hmp = if collection center (m) open in period) than 1, otherwise; 0
14
Reverse Logistics in Pharmaceutical Industry
Other parameters
Gqp = Capacity of the warehouse (Q) in Period (P)
Emp= Capacity of the collection center (m) in period (p)
Fmx1p= capacity of the destruction point (x1) at collection center (m) in period (p)
Fmx2p= capacity of the disposal point (x2) at collection center (m) in period (p)
Yqx1p= capacity of the destruction point (x1) at warehouse (q) in period (p)
Yqx2p= capacity of the disposal point (x2) at warehouse (q) in period (p)
kmdp= Distance of collection center (m) form distribution (d) in period (p) (Distance in
Km)
K qdp= Distance of warehouse (q) form distribution (d) in period (p) (Distance in Km)
Cmp= cost of opening of collection center (m) in period (p) (pak/collection center)
T = unit cost of the shipping a product at warehouse from distribution (Pak/ton)
T1= unit cost of the shipping a product at from collection point from distribution
(Pak/ton)
CXimp= cost of destruction (x2) at collection center (m) in period (p)
Cx2mp= cost of disposal (x2) at collection center (m) in period (p)
ZXiqp= cost of destruction (x2) at warehouse (q) in period (p)
Zx2qp= cost of disposal (x2) at warehouse (q) in period (p)
LC = cost of land cleaning from warehouse (q) in period (p)
LC1= cost of cleaning from collection points (m) in period (p) (LC= 1, 2, ---, n)
SC = cost of subcontracting (sc) the process at warehouse Point (q) in period (p)
SC1 = cost of subcontracting (sc) the process at collection centers (m) in period (p)
15
Reverse Logistics in Pharmaceutical Industry
Objective function
To minimize
n n n n n
dp pd mdp mp
P m p
n n n n n n
R pm C mp R pm C mp
m p m p
n n n n n n
M p p M p p
m p m p
n n n n n
mp Cmp mdp LC mp
p m m p
n n n n n
dp LCpd mdp SC mp
P m p
n n
dp SCpd
P
16
Reverse Logistics in Pharmaceutical Industry
With Subjected To
n
1. dp p p,d,c
2. mdp mp
3. w mpd- R pm R pm p,m,
4. R pm mp
5. R pm mp
6.
7. T > t1
8. pd - M p M p p,m,
9. M p p
10. M p p
11. LC < LC1
12. Hmp = { 0 ,1}
13. Gqp , Emp , Fmx1p , Fmx2 , Yqx1p , Yqx2 p
14. Kmdp , K qdp , Cmp
15. T , T1 ‘ CXimp , ZXiqp , Cx2mp , Zx2qp
Objective function has multiple components, which include the cost of
shipping form distributors at warehouse facility, cost of return received in collection
centers, cost of distraction in collection house, , cost of destruction at warehouse
facility , cost of disposal at warehouse facility , cost of disposal in collection house
and cost of opening a new collection center a, cost of land cleaning at collection
centers and warehouse facilities, subcontracting cost in case of warehouse facility or
17
Reverse Logistics in Pharmaceutical Industry
subcontracting cost for collection centers and finally cost of opening a collection
centers in given periods and planning horizon. Constrains (1, 2) include reverse
returns received from distributors and capacity of the collection centers. Constrain (3)
set the limit that the total inventory which is returned from the distributor should be
zero when allocated to the destruction and disposal units within the collection center,
constrain (4, 5) describes the capacity of the destruction and disposal points at
collection centers. Rests of the constraints is the facility opening constrains. Constrain
(7) states that the cost of transportation from distribution point to warehouse return
facility will be more than the cost of transportation from distribution to collection
points. Constrain (8 – 10) discuss the facility capacity and return stock allocation.
Constrain (11) states that the Land cleaning cost at warehouse return facility will be
lesser then the cost of land cleaning at collection points. Rests of the constrains is the
non- negative constrains.
Conclusion:
In this paper, the return part in the Pharmaceutical industry has been modeled
using the multiple integer linear programming. Paper investigate the reverse logistics
when company have multiple product line and having the wide operations overall in
the Pakistan , and planning to open collection centers to optimize the customer
service level by consider the best cost. The model has ability to consider if in long
term the company is planning to open the facility or outsource network then the
model will help to make decision. In future if the organization taking the uncertainty
in demand and return rate then fuzzy can be incorporated in the model which may be
tool to cope such issues.
18
Reverse Logistics in Pharmaceutical Industry
Reference
CSCMP’s Definition of Logistics Management, (2013). Retrieved from
http://cscmp.org/about-us/supply-chain-management-definitions.
Jayaraman, V., Guide Jr, V.D.R., and Srivastava, R. (1999). A closed-loop logistics
model for remanufacturing. The Operational Research Society, 50(5), 497–
508.
Khan, A., & Subzwari, M. (2009). Reverse Logistics in Pakistan’s Pharmaceutical
Sector. South Asian Journal of Management Sciences, 3(1), 27-36.
Pakistan Association of Pharmaceutical Industry (n.d). Retrieved from
http://ppma.org.pk/PPMAIndustry.aspx.
Pervez, A. (2008). Pakistan Pharmaceutical Sector, OSEC Business Network
Switzerland.
Chopra, S. (2009). Supply Chain Management: What is Supply Chain Management?
Roghanian, E &Hosseinzadeh, M. (2012). An Optimization Model for Reverse
Logistics Network under Stochastic Environment Using Genetic Algorithm.
International Journal of Business and Social Science, 3(12)
Umer, M., & Afzal, F. (2012) Analysis of Reverse Logistics in Soft-Drink Bottling
Industry of Pakistan. Proceedings of 2nd International Conference on
Business Management. Lambert academic publishing.
19
Reverse Logistics in Pharmaceutical Industry
Yousuf, I. Reverse logistics framework. Proceedings of 2nd International Conference
on Business Management.
20